Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prevalence of Colon Cancer in Pyogenic Liver Abscess

This study has been completed.
Sponsor:
Collaborator:
Pusan National University Yangsan Hospital
Information provided by (Responsible Party):
Tae Oh Kim, Inje University
ClinicalTrials.gov Identifier:
NCT02032914
First received: January 8, 2014
Last updated: February 26, 2016
Last verified: February 2016
  Purpose
Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

Condition Phase
Cryptogenic Pyogenic Liver Abscess
Phase 4

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 3 Months
Official Title: The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess

Resource links provided by NLM:


Further study details as provided by Inje University:

Primary Outcome Measures:
  • The prevalence of colonic neoplasm [ Time Frame: within 6 weeks after diagnosis of pyogenic liver abscess ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Prevalence of colon polyp [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ] [ Designated as safety issue: No ]
  • Prevalence of colonic diverticulitis [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ] [ Designated as safety issue: No ]
  • Prevalence of inflammatory bowel disease [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ] [ Designated as safety issue: No ]
  • Prevalence of intestinal tuberculosis [ Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess ] [ Designated as safety issue: No ]

Enrollment: 62
Study Start Date: January 2014
Study Completion Date: February 2016
Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts
Colonoscopic examination group
The patients diagnosed with cryptogenic pyogenic liver abscess

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The patients diagnosed as pyogenic liver abscess, the cause of which is not found at initial evaluation
Criteria

Inclusion Criteria:

  • Pyogenic liver abscess radiologically and bacteriologically diagnosed

Exclusion Criteria:

  • Amebic liver abscess
  • Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma
  • Refusal to colonoscopic examination
  • Inadequate general patient status to perform the colonoscopic examination
  • Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02032914

Locations
Korea, Republic of
Pusan National Unversity Yangsan Hospital
Yangsan-si, Gyeongsangnam-do, Korea, Republic of
Inje University Haeundae Paik Hospital
Busan, Korea, Republic of
Sponsors and Collaborators
Inje University
Pusan National University Yangsan Hospital
Investigators
Principal Investigator: Tae Oh Kim, M.D. Inje University Haeundae Paik Hosptial
  More Information

Responsible Party: Tae Oh Kim, Assistant professor, Inje University
ClinicalTrials.gov Identifier: NCT02032914     History of Changes
Other Study ID Numbers:
Study First Received: January 8, 2014
Last Updated: February 26, 2016
Health Authority: Korea: Ministry for Health and Welfare

Keywords provided by Inje University:
pyogenic liver abscess
colon cancer

Additional relevant MeSH terms:
Abscess
Liver Abscess
Liver Abscess, Pyogenic
Suppuration
Infection
Inflammation
Pathologic Processes
Abdominal Abscess
Liver Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on September 26, 2016